2018

UBIP B-Raf anti-cancer targeted new drug UB-941 has won the 15th National Innovation Award.

張秀蓮 and 陳啟祥 respectively assume the positions of Chairperson and General Manager at UBIP.

UBIP's "RECOMBINANT PROTEIN" technology platform has obtained a patent certificate from the European Union.

UBIP has been honored with the 15th Taiwan Golden Root Award.

UBIP collaborates with the American company Qiji to establish a multifunctional protein drug production base in Yangzhou.